Skip to main content
. 2015 Sep;12(5):315–324. doi: 10.1177/1479164115588548

Table 3.

Medical treatment at baseline.

Medication NGT IGT T2DM p value
Oral anti-diabetic agent 0 0 63 <0.001
Beta-blocker 10 30 13 <0.05
ACE inhibitor 3 9 24 <0.001
Angiotensin II receptor blocker 7 15 24 <0.05
Statin 4 9 50 <0.001

NGT: normal glucose tolerance; IGT: impaired glucose tolerance; T2DM: type 2 diabetes mellitus; ACE: angiotensin-converting-enzyme.

The data are expressed as the percentage of participants in each group. Group comparisons by the chi-square exact test.